Hepatitis C Clinical Trials


Hepatitis C Infection in World Trade Center Responders

This study provides Hepatitis C virus screening to the members of the World Trade Center Health Program followed at the Icahn School of Medicine at Mount Sinai born during 1945-1965, and linkage to care for those found infected. The stud...

Learn More

Maraviroc Efficacy for Hepatitis C (MAVERIC)

This is a single-site, longitudinal, open-label, interventional study for evaluating the effect of maraviroc on hepatitis C viral levels in patients infected with both hepatitis C and human immunodeficiency virus (HIV) and taki...

Learn More

Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection (Care2Cure)

Effective all-oral medications are finally available to cure hepatitis C virus, which affects more than 4 million Americans and one-in-four people living with HIV. However, many barriers exist that prevent people with HIV/HCV co-infectio...

Learn More

Hepatitis c and Vitamin D and Iron Status

Condition:   Hepatitis C
Interventions:   Drug: Sofosbuvir 400 mg;   Drug: Daclatasvir 60 mg/day
Sponsor:   Eman Sayed Hassan Abd Allah
Not yet recruiting - verified May 2017

Learn More

Hepatitis C Infection in World Trade Center Responders

Condition:   Hepatitis C Infection
Intervention:  
Sponsors:   Icahn School of Medicine at Mount Sinai;   Centers for Disease Control and Prevention;   National Institute for Occupational Safety and Health (NIOSH/CDC)
Recruiting - verified December 2016

Learn More

The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital

Condition:   Hepatitis C
Intervention:   Other: community based hepatitis C care and treatment
Sponsors:   Macfarlane Burnet Institute for Medical Research and Public Health Ltd;   St Vincent's Hospital Melbourne
Not yet recruiting - verified September 2015

Learn More

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

Conditions:   Hepatitis C;   Chronic Hepatitis C
Interventions:   Other: Mailer;   Other: In-person recruitment;   Other: EHR Alert
Sponsors:   National Opinion Research Center;   NORC at the University of Chicago;   University of Alabama at Birmingham;   Henry Ford Health System;   Icahn School of Medicine at Mount Sinai;   Centers for Disease Control and Prevention
Completed - verified March 2015

Learn More

Hepatitis C in Renal Transplant Recipients

Conditions:   Chronic Hepatitis C-virus Infection;   Renal Transplantation
Intervention:   Drug: tacrolimus-cyclosporine A
Sponsor:   Prof. Dr. Alice Schmidt
Unknown status - verified April 2014

Learn More

Surveillance and Treatment of Prisoners With Hepatitis C

Condition:   Hepatitis C
Intervention:   Drug: Sofosbuvir/velpatasvir
Sponsor:   Kirby Institute
Recruiting - verified August 2016

Learn More

Undiagnosed Hepatitis C Infection in an Urban Hospital

Condition:   Hepatitis C
Intervention:   Other: Observation only, no intervention
Sponsors:   Temple University;   Janssen Services, LLC
Completed - verified February 2016

Learn More

Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated With Peginterferon Alpha-2a and Ribavirin

Condition:   Chronic Hepatitis C
Intervention:   Device: chronic hepatitis C
Sponsors:   Seoul National University Boramae Hospital;   Roche Pharma AG
Active, not recruiting - verified October 2016

Learn More

Q-Trial in Patients With Hepatitis C

Condition:   Chronic Hepatitis C
Intervention:   Dietary Supplement: Quercetin
Sponsors:   University of California, Los Angeles;   American Association for Cancer Research;   Tower Cancer Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified March 2015

Learn More

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Conditions:   Hepatitis C;   Renal Cell Carcinoma;   Colorectal Cancer
Intervention:   Other: Hepatitis C testing
Sponsors:   Henry Ford Health System;   Schering-Plough
Completed - verified September 2014

Learn More

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Condition:   Hepatitis C
Intervention:  
Sponsors:   Pennine Acute Hospitals NHS Trust;   Roche Pharma AG
Unknown status - verified March 2011

Learn More

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Condition:   Chronic Hepatitis C
Interventions:   Procedure: Blood sampling of peripheral blood mononuclear cells;   Procedure: Blood draw, 20ml peripheral blood mononuclear cells
Sponsor:   University of Nebraska
Terminated - verified January 2010

Learn More

1-15 of 23
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.